FDA Import Refusal 1FX-7004561-2/10002/4 — Reckitt Benckiser Healthcare India Private Limited
The FDA refused shipment 1FX-7004561-2/10002/4 from Reckitt Benckiser Healthcare India Private Limited (India) on Jul 31, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 31, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GBY99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 75